Cited by 93Diabetes, Cardiovascular Risks, and LipoproteinsCardiac Health and Mental HealthAdipokines, Inflammation, and Metabolic Diseases

The relationship between depression and risk of metabolic syndrome: a meta‐analysis of observational studies

Open access
Moradi, Yousef, Albatineh, Ahmed N, Mahmoodi, Hassan, Gheshlagh, Reza Ghanei·2021·Clinical Diabetes and Endocrinology

Abstract

INTRODUCTION: The link between metabolic syndrome and depression has always been controversial. Different studies that have examined the relationship between metabolic syndrome and depression have reported different results. Therefore, the goal of the present study was to examine the association between depression and MetS by meta-analysis. METHODS: Embase, Scopus, PubMed, and ISI were searched for publications in English from January 1990 to February 2020. Search included cohort and cross-sectional studies aimed at examining the association between depression and MetS. The risk of bias was assessed by Newcastle-Ottawa Scale. Heterogeneity and publication bias were tested, subgroup analysis and meta-regression were conducted. RESULTS: 49 studies with total sample size 399,494 were analyzed. Results indicated the odds of MetS was higher in depressed compared to non-depressed individuals [OR: 1.48; 95 %CI: 1.33-1.64) vs. (OR: 1.38; 95 %CI: 1.17-1.64)]. For cross-sectional studies, depressed patients in Europe (OR = 1.35; 95 %CI: 1.47-1.99) were at higher odds of MetS compared to those in America and Asia. For cohort studies, depressed patients in America (OR = 1.46; 95 %CI: 1.16-1.84) were at higher odds of MetS than those in Europe. Cross-sectional studies indicated women with depression were at higher odds of MetS (OR = 1.95; 95 %CI: 1.38-2.74) compared to men. In both types of studies, the odds of MetS decreased with age. CONCLUSIONS: Metabolic syndrome is more common in depressed compared to non-depressed individuals.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s40842-021-00117-8

Cites

78 of 78 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • People with MDD are 1.38 times more likely than the general population to develop the metabolic syndrome (95% CI 1.17-1.64).

    “People with MDD are 1.38 (95% CI: 1.17-1.64) times more likely than the general population to develop the metabolic syndrome63, while people with the metabolic syndrome are 1.49 (95% CI: 1.20-1.87) times more likely to develop MDD10.”

    From Comorbidity between major depressive disorder and physical diseases: a comprehensive review of epidemiology, mechanisms and management (2023) · cites this paper as [63]

    The Results section, “Meta-analysis of cohort studies” (page unavailable), reports a pooled risk ratio of 1.38 (95% CI 1.17–1.64) for metabolic syndrome in people with depression. The estimate pools studies using several depression measures, so it is not specific to diagnosed MDD; the relevant comparison is with people without depression, not the general population as a whole. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

2 of the 80 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Moradi, Y., Albatineh, A. N., Mahmoodi, H., & Gheshlagh, R. G.
Affiliations
  • Kurdistan University of Medical Sciences (IR)
  • Kuwait University (KW)
Corresponding author
Gheshlagh, Reza Ghanei
Venue
Clinical Diabetes and Endocrinology
Published
2021-03-02
Volume
7
Issue
1
Pages
4-4
ISSN
2055-8260 (ISSN-L)
OpenAlex
W3135765840
Cited by
93
References
80
Citations by year
2026: 15 · 2025: 20 · 2024: 21 · 2023: 18 · 2022: 16 · 2021: 3
FWCI
10.83
Type
journal article
Language
en
Open access
Locations
  • Clinical Diabetes and Endocrinology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
  • Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
Keywords
depression, metabolic syndrome, sex differences, age differences, regional variation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review